Wired for What’s Next.
Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is December 17, 2023.
All times in Eastern Time.
-
UofT Campus Community Uniting for Holiday Solidarity Rally
TORONTO--(BUSINESS WIRE)--Workers and students from across the University of Toronto campuses will come together for a Holiday Solidarity Rally in front of Simcoe Hall at 3:00 p.m. on Monday, Decem... more » -
InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-332 Meet Primary Endpoint in Patients with Atomic DermatitisBEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that phase II ... more »
-
Rent Control Vital as Homelessness SoarsLOS ANGELES--(BUSINESS WIRE)--Rent Control Vital as Homelessness Soars more »
-
Artificial Intelligence and Commerce Collide at The RETHINK Retail Gala January 15th, 2024 in NYC
NEW YORK--(BUSINESS WIRE)--Prepare to witness the intersection of style and innovation as The RETHINK Retail Gala takes center stage on January 15th, 2024, at a secret venue in New York City. This ... more » -
UNITE HERE Local 11: Major Breakthrough! Nine Marriott Hotels and One More Hilton Sign Agreements, Doubling Total to Twenty in Less than A Week
LOS ANGELES--(BUSINESS WIRE)--More than 1700 housekeepers, cooks, dishwashers, servers, and front desk workers at nine Marriott hotels – Irvine Marriott, W Hotel Westwood, SLS Beverly Hills, Westin... more » -
Visa Provisioning Intelligence setzt zur Bekämpfung von Token-Betrug an
SAN FRANCISCO--(BUSINESS WIRE)--Visa (NYSE: V), ein weltweit führendes Unternehmen im Zahlungsverkehr, gab heute die Markteinführung von Visa Provisioning Intelligence (VPI) bekannt, einem KI-basie... more » -
GM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that General Motors Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: General Motors business and prospects, resulting in its stock trading at inflated prices. more » -
California American Water Continues to Fight Condemnation Effort
MONTEREY, Calif.--(BUSINESS WIRE)--California American Water announced today that it will vigorously defend its right to continue to serve the customers and the communities in its Monterey Peninsul... more » -
Takeda recibe la opinión positiva del CHMP para HYQVIA® como terapia de mantenimiento en pacientes con polineuropatía desmielinizante inflamatoria crónica (PDIC)
OSAKA, Japón, y CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) anunció hoy que el Comité de Medicamentos de Uso Humano (CHMP) de la Agencia Europea de Medicamentos (EMA) ha r... more » -
Takeda obtient l’avis favorable du CHMP pour HYQVIA® en tant que traitement d’entretien chez les patients atteints de polyneuropathie inflammatoire démyélinisante chronique (PDIC)
OSAKA, Japon et CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) a annoncé aujourd’hui que le Comité des médicaments à usage humain (CHMP) de l’Agence européenne des médicament... more » -
Takeda就HYQVIA®作为慢性炎症性脱髓鞘性多神经病变(CIDP)患者的维持疗法获得CHMP积极意见
日本大阪和马萨诸塞州坎布里奇--(BUSINESS WIRE)--(美国商业资讯)-- Takeda (TSE:4502/NYSE:TAK) 今天宣布，欧洲药品管理局(EMA)人用医药产品委员会(CHMP)建议批准HYQVIA®[10%免疫球蛋白（人体）注射液结合重组人体透明质酸酶]用于慢性炎症性脱髓鞘性多神经病变(CIDP)患者，作为静脉注射免疫球蛋白疗法(IVIG)稳定后的维持疗法。欧盟... more » -
Takeda erhält positive CHMP-Stellungnahme für HYQVIA® als Erhaltungstherapie bei Patienten mit chronisch entzündlicher demyelinisierender Polyneuropathie (CIDP)
OSAKA, Japan, und CAMBRIDGE, Massachusetts--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) gab heute bekannt, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur (EMA... more » -
Takeda就HYQVIA®作為慢性脫髓鞘多發性神經炎(CIDP)病患的維持療法獲得CHMP肯定意見
日本大阪和麻塞諸塞州劍橋--(BUSINESS WIRE)--(美國商業資訊)-- Takeda (TSE:4502/NYSE:TAK) 今天宣布，歐洲藥品管理局(EMA)人用醫藥產品委員會(CHMP)建議核准HYQVIA®[含人類化重組玻尿酸水解酶的10%人體免疫球蛋白輸注液]用於慢性脫髓鞘多發性神經炎(CIDP)病患，作為靜脈注射免疫球蛋白療法(IVIG)穩定後的維持療法。歐盟委員會(E... more » -
武田薬品、慢性炎症性脱髄性多発根神経炎（CIDP）に対する維持療法としてのHYQVIA®について、CHMPの肯定的意見を取得
日本・大阪およびマサチューセッツ州ケンブリッジ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 武田薬品工業株式会社 （東京証券取引所：4502/ニューヨーク証券取引所：TAK）は、欧州医薬品庁（EMA）ヒト用医薬品委員会（CHMP）が、慢性炎症性脱髄性多発根神経炎（CIDP）に対する安定した静注免疫グロブリン（IVIG）療法後の維持療法としてのHYQVIA®［遺伝子組換えヒト... more » -
アルファウェーブ・セミがKeysightと提携し、業界をリードする専門知識と完全なPCIe 6.0サブシステムソリューションの相互運用性を提供
ロンドン＆トロント--(BUSINESS WIRE)--（ビジネスワイヤ） -- 世界のテクノロジー・インフラの高速接続を提供するグローバルリーダーである アルファウェーブ・セミ（LSE：AWE）は、設計、エミュレーション、およびテスト・ソリューションのマーケット・リーダーであるKeysight Technologiesとの提携を発表し、 アルファウェーブ・セミのPCIe 6.0 64 GT... more »